Use of cannabis or cannabis products to treat disease or alleviate symptoms by patient choice, * understanding that there is a lack of placebo-controlled trials supporting the favorable efficacy and safety of these products.
*The DEA also recently affirmed maintaining marijuana as a Schedule I substance.
The 2018 Farm Bill descheduled CBD having less than 0.3% THC by dry weight, these products must not be used as supplements or foods, nor can it be used to treat a medical condition.